Azenta, Inc. (AZTA) Stock
NASDAQ · AZTA
Key stats
- Market cap
- $2.04B
- Price / Earnings ratio
- -14.4x
- EPS (TTM)
- -$2.67
- Volume
- Loading
- 52-week high
- $46.41
- 52-week low
- $15.93
Source: third-party data provider, as of November 13, 2026
Compare with AZTA
Recent news

Business Wire
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
AZTASeptember 26, 2026
Business Wire
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
AZTA

MarketBeat
Azenta Q3 Earnings Call Highlights
AZTAAugust 5, 2026
MarketBeat
Azenta Q3 Earnings Call Highlights
AZTA

Business Wire
Azenta, Inc. (AZTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
AZTAMay 22, 2026
Business Wire
Azenta, Inc. (AZTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
AZTA

Business Wire
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
AZTAMay 22, 2026
Business Wire
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
AZTA
Technical indicators
- RSI 14
- 71.26
- MACD 12/26/9
- 1.81
- EMA 9 of MACD
- 1.11
- MACD histogram
- 0.70
- SMA 50
- $35.99
- Price above SMA 50
- EMA 50
- $36.52
- Price above EMA 50
- SMA 200
- $28.36
- Price above SMA 200
- EMA 200
- $31.49
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 2 analyst ratings
Strong Sell0
Sell0
Hold0
Buy2
Strong Buy0
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Revenue
Net income
Net margin %
2021
2022
2023
2024
2025
3B2B845M0
Debt & Balance Sheet
Total assets
Total liabilities
2021
2022
2023
2024
2025
4B3B1B0
Revenue to Profit
2025$593.8M
Revenue$0.0
Cost of revenue$270.3M
Gross profit$0.0
Operating expenses$-55.8M
Net incomeEarnings
No data available
Source: third-party data provider
Latest news

Business Wire
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
AZTASeptember 26, 2026
Business Wire
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
AZTA

MarketBeat
Azenta Q3 Earnings Call Highlights
AZTAAugust 5, 2026
MarketBeat
Azenta Q3 Earnings Call Highlights
AZTA

Business Wire
Azenta, Inc. (AZTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
AZTAMay 22, 2026
Business Wire
Azenta, Inc. (AZTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
AZTA

Business Wire
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
AZTAMay 22, 2026
Business Wire
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
AZTA

Business Wire
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
AZTAMay 22, 2026
Business Wire
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
AZTA

Business Wire
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
AZTAMay 13, 2026
Business Wire
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
AZTA

Business Wire
Azenta, Inc. (AZTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
AZTAMay 13, 2026
Business Wire
Azenta, Inc. (AZTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
AZTA

Business Wire
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
AZTAMay 12, 2026
Business Wire
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
AZTA

Business Wire
AZENTA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
AZTAMay 9, 2026
Business Wire
AZENTA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
AZTA

Zacks Investment Research
New Strong Sell Stocks for January 8th
AZTAJanuary 8, 2026
Zacks Investment Research
New Strong Sell Stocks for January 8th
AZTA
About Azenta, Inc.
No description available.
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees2,900
CEODr. Martin D. Madaus D.V.M., Ph.D.
IPO DateFeb 2, 1995
HeadquartersBurlington, MA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Martin D. Madaus D.V.M., Ph.D. | Interim President, CEO & Director | 1960 |
| Mr. Lawrence Y. Lin | Executive VP & CFO | 1977 |
| Mr. Ephraim Starr | Senior VP, General Counsel & Corporate Secretary | 1972 |
| Ms. Olga Pirogova | Senior VP & Chief HR Officer | 1974 |
| Dr. Ginger Zhou Ph.D. | Advisor | 1977 |
| Mr. Erik J. Bello | Vice President, Chief Accounting Officer & Principal Accounting Officer | — |
| Mr. Michael Paulo | VP, Chief Information & Digital Officer | — |
| Ms. Yvonne Perron | Vice President of Financial Planning & Analysis and Investor Relations | — |
| Mr. William E. Martin III | Senior Vice President & President of Multiomics | 1975 |
| Dr. Andrea O'Hara Ph.D. | Strategic Technical Specialist of Azenta Life Sciences | — |
Fundamentals
Valuation
Price-to-sales ratio3.03
Price-to-book value1.17
PEG ratio0.53
Profitability
Return on Equity-8.00%
Return on Assets-6.00%
Return on Sales-27.00%
Gross margin (latest quarter)44.89%
EBITDA$-107.70M
Trading
Average volume905,952
Dividend
Ex dividend date2 Dec 2021
Last payment date23 Dec 2021
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 71.26
- MACD 12/26/9
- 1.81
- EMA 9 of MACD
- 1.11
- MACD histogram
- 0.70
- SMA 50
- $35.99
- Price above SMA 50
- EMA 50
- $36.52
- Price above EMA 50
- SMA 200
- $28.36
- Price above SMA 200
- EMA 200
- $31.49
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Analyst consensus:Buy
100% Buy
0% Hold
0% Sell
Analyst price target
- Low
- $37.00
- Average
- $44.50
- High
- $52.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -8.8 | |||||||||||
| 2022 | -18.8 | +2.3 | -3.7 | -11.7 | +2.0 | -3.8 | -3.7 | -22.1 | -17.3 | -0.2 | +31.9 | -5.8 |
| 2023 | -5.2 | -24.5 | +2.1 | -2.2 | -0.9 | +7.2 | +2.0 | +22.4 | -11.2 | -8.7 | +24.4 | +12.4 |
| 2024 | +0.5 | -1.5 | -10.4 | -11.1 | -3.1 | +3.3 | +22.0 | -17.3 | +1.1 | -13.5 | +12.1 | +5.9 |
| 2025 | +8.0 | -16.3 | -15.7 | -22.8 | +1.9 | +15.6 | +3.0 | -5.6 | -4.8 | -4.4 | +15.7 | -4.6 |
| 2026 | +16.4 | -28.1 | -18.2 | +16.0 | -8.1 | +10.0 | +7.4 | +9.3 | +10.5 | +13.3 | +37.6 |
Corporate actions
Upcoming
No upcoming corporate actions for AZTA
Past
DividendQ4/21
Ex-dividend date2 Dec 2021
Payable date23 Dec 2021
Amount per share$0.10
Compare stocks
Market cap
$2.04B
-
-
-
Price / Earnings ratio
-14.40
-
-
-
Price / Sales ratio
3.03
-
-
-
Dividend yield
0.00%
-
-
-
Average volume
905,952
-
-
-
Earnings per share
$-2.67
-
-
-



